Search Results

Methodological and statistical considerations: Batch-dependent adverse effects of COVID-19 vaccines.

• Authors : Scott DAR; Department of Ophthalmology, Greenlane Clinical Centre, Te Whatu Ora Health New Zealand, Auckland, New Zealand.; Department of Ophthalmology, University of Auckland, Auckland, New Zealand.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

• Source: European journal of clinical investigation [Eur J Clin Invest] 2023 Dec; Vol. 53 (12), pp. e14073. Date of Electronic Publication: 2023 Aug 07.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Batch‐dependent safety of COVID‐19 vaccines in the Czech Republic and comparison with data from Denmark.

• Authors : Fürst, Tomáš¹ (AUTHOR); Šourek, Petr² (AUTHOR); Krátká, Zuzana³ (AUTHOR)

• Source: European Journal of Clinical Investigation. Oct2024, Vol. 54 Issue 10, p1-6. 6p.

Record details

Evidence base for yearly respiratory virus vaccines: Current status and proposed improved strategies.

• Authors : Barosa M; NOVA Medical School, NOVA University of Lisbon, Lisbon, Portugal.; Ioannidis JPA

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; Influenza Vaccines*/Influenza Vaccines*/Influenza Vaccines*/immunology

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Oct; Vol. 54 (10), pp. e14286. Date of Electronic Publication: 2024 Jul 30.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine.

• Authors : Jara-Palomares L; RIETE Investigators

Subjects: Anticoagulants*/Anticoagulants*/Anticoagulants*/adverse effects ; Anticoagulants*/Anticoagulants*/Anticoagulants*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Dec; Vol. 54 (12), pp. e14310. Date of Electronic Publication: 2024 Sep 04.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

COVID-19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy.

• Authors : du Preez HN; Catalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, South Africa.; College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Oct; Vol. 54 (10), pp. e14296. Date of Electronic Publication: 2024 Aug 08.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Lung damage in SARS-CoV-2 patients: An autopsy study in the era of vaccination.

• Authors : Bussani R; Institute of Pathological Anatomy and Histology, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/mortality ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use

• Source: European journal of clinical investigation [Eur J Clin Invest] 2025 Jan; Vol. 55 (1), pp. e14325. Date of Electronic Publication: 2024 Sep 29.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Re: 'Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals'.

• Authors : Daungsupawong H; Private Academic Consultant, Phonhong, Lao People's Democratic Republic.; Wiwanitkit V

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 May; Vol. 54 (5), pp. e14170. Date of Electronic Publication: 2024 Jan 19.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

HLA binding‐groove motifs are associated with myocarditis induction after Pfizer‐BioNTech BNT162b2 vaccination.

• Authors : Aharon, Aviran¹ (AUTHOR); Benedek, Gil^1,2 (AUTHOR); Barhoum, Barhoum³ (AUTHOR)

• Source: European Journal of Clinical Investigation. Apr2024, Vol. 54 Issue 4, p1-7. 7p.

Record details

Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria.

• Authors : Chalupka A; Institute for Surveillance & Infectious Disease Epidemiology, Austrian Agency for Health and Food Safety (AGES), Vienna, Austria.; Richter L

Subjects: COVID-19 Vaccines* ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

• Source: European journal of clinical investigation [Eur J Clin Invest] 2024 Mar; Vol. 54 (3), pp. e14136. Date of Electronic Publication: 2023 Nov 30.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

Batch-dependent safety of the BNT162b2 mRNA COVID-19 vaccine.

• Authors : Schmeling M; Innometric, Skørping, Denmark.; Manniche V

Subjects: BNT162 Vaccine* ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

• Source: European journal of clinical investigation [Eur J Clin Invest] 2023 Aug; Vol. 53 (8), pp. e13998. Date of Electronic Publication: 2023 Apr 09.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details